T. Rowe Price Associates »

Amylyx Pharmaceuticals shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $13M 895k 14.72
2023-09-30 $444k 24k 18.33
2023-06-30 $499k 23k 21.61
2023-03-31 $661k 23k 29.37
2022-12-31 $579k 16k 36.92